Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Permethrin for Scabies in Infants and Young Children
NCT07247630Phase 1Not yet recruiting
- Sponsor
- College of Physicians and Surgeons Pakistan
- Start
- Jan 2026
- Primary completion
- Mar 2026
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1 trial of permethrin in scabies (2 arms), sponsored by College of Physicians and Surgeons Pakistan. Primary endpoint: Treatment of scabies at 15 days. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
permethrin
03
Conditions
scabies
Beyond the preview
Go deeper on NCT07247630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07247630.